Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biogen Idec, Elan seek to update Tysabri labeling
Marketwatch
Wednesday, December 22, 2010 - 9:00am
tags:
Elan, Biogen Idec, Tysabri, MS, multiple sclerosis
Arena eyes obesity drug refiling by end of 2011
Reuters
Wednesday, December 22, 2010 - 8:55am
tags:
Arena Pharmaceuticals, obesity, FDA
Former drug rep sues for unlawful discharge
The Record, West Virginia
Wednesday, December 22, 2010 - 8:53am
tags:
drug reps, Novo Nordisk
Is Genzyme Ready to Cave to Sanofi?
WSJ Online
Wednesday, December 22, 2010 - 8:52am
tags:
Sanofi, M&A, Genzyme
Anti-Smoking Drug Linked to Violence, but Pfizer’s Data Says the Opposite
BNET Pharma
Wednesday, December 22, 2010 - 8:19am
tags:
smoking cessation, Pfizer, Chantix
J&J Directors Ignored `Red Flags' on Recalls, Probes, Suit Says
Bloomberg
Wednesday, December 22, 2010 - 8:17am
tags:
JNJ, recalls
Sanofi-Aventis Continues to Beef Up Oncology Pipeline With New Strategic Alliance
Seeking Alpha
Wednesday, December 22, 2010 - 8:16am
tags:
oncology, Sanofi, Avila
Vertex Ends Part of Telaprevir Study for Hepatitis C
Bloomberg
Wednesday, December 22, 2010 - 8:15am
tags:
hepatitis C, Vertex Pharmaceuticals, Telaprevir
J&J’s Contractor for Tainted Rolaids Faces Scrutiny
Bloomberg
Wednesday, December 22, 2010 - 8:14am
tags:
JNJ, Rolaids, recalls
Biotech, Where Winners Lose
Forbes
Tuesday, December 21, 2010 - 5:49pm
tags:
biotech
Teva will market generic Actos starting in 2012
Yahoo/AP
Tuesday, December 21, 2010 - 5:46pm
tags:
generics, Actos, Teva Pharmaceuticals, Takeda, diabetes
4 Drugmakers, 5 Deals, Christmas Is Here
Motley Fool
Tuesday, December 21, 2010 - 4:34pm
tags:
Abbott Laboratories, Pfizer, Bristol-Myers Squibb, Sanofi, Lpath, Avila, Oncolys BioPharma, Phylogica, EpiTherapeutics
Xoma shares rocket on diabetes drug research report
Bizjournals.com
Tuesday, December 21, 2010 - 4:32pm
tags:
diabetes, Xoma, XOMA 052, IL-1 inhibitor
Genzyme more willing to talk to Sanofi: WSJ
Yahoo/Reuters
Tuesday, December 21, 2010 - 2:11pm
tags:
Genzyme, Sanofi, M&A
Martek to be acquired by Royal DSM for $1.09B
Bizjournals.com
Tuesday, December 21, 2010 - 2:10pm
tags:
Martek, Royal DSM, M&A
When is a High Sense of Urgency a Liability for Pharmaceutical Companies?
Pharmareform
Tuesday, December 21, 2010 - 10:58am
tags:
pharma industry
Merck KGaA to pay $280M on Dey's alleged price fraud
Fierce Pharma
Tuesday, December 21, 2010 - 10:52am
tags:
Merck KGaA, Dey, price fraud
Novartis Pill for Untreatable Multiple Sclerosis Might Reap $5.4 Billion
Bloomberg
Tuesday, December 21, 2010 - 10:48am
tags:
Novartis, MS, multiple sclerosis, Gilenya
InterMune – The Black Knight Of Biotech?
Investopedia
Tuesday, December 21, 2010 - 10:46am
tags:
biotech, InterMune, Genzyme, Gilead Sciences, GSK, Pfizer, Roche
House Democrats Introduce Drug Safety Legislation
Pharmalot
Tuesday, December 21, 2010 - 10:43am
tags:
drug safety, drug safety legislation, healthcare reform

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.